The high 91% trader consensus on “No” for a new COVID variant of concern before 2027 stems from sustained low public-health risk assessments across global surveillance. As of late July 2026, neither the WHO nor ECDC lists any SARS-CoV-2 lineage as a variant of concern; monitored strains such as BA.3.2, NB.1.8.1, and XFG show no evidence of meaningfully higher severity, hospitalization, or immune escape that would trigger formal designation. Recent data through June indicate these subvariants are circulating at stable or declining levels with limited impact relative to prior waves. With only five months remaining and no accelerating signals in genomic or wastewater tracking, the market reflects the slim likelihood of rapid escalation before year-end.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourOui
$243,750 Vol.
$243,750 Vol.
Oui
$243,750 Vol.
$243,750 Vol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Marché ouvert : Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...The high 91% trader consensus on “No” for a new COVID variant of concern before 2027 stems from sustained low public-health risk assessments across global surveillance. As of late July 2026, neither the WHO nor ECDC lists any SARS-CoV-2 lineage as a variant of concern; monitored strains such as BA.3.2, NB.1.8.1, and XFG show no evidence of meaningfully higher severity, hospitalization, or immune escape that would trigger formal designation. Recent data through June indicate these subvariants are circulating at stable or declining levels with limited impact relative to prior waves. With only five months remaining and no accelerating signals in genomic or wastewater tracking, the market reflects the slim likelihood of rapid escalation before year-end.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour



Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes